Kirby John J.
SEC CIK 1556327 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Interim CFO | 24.0K | $39.6K | — | 4 | 2024-11-06 | 2026-08-18 |
Most active insiders at VRCA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Manning Paul B | Dir, 10% | $17.49M | — |
| 2 | Rieger Jayson | CEO, Pres, Dir | $525.6K | — |
| 3 | Zawitz David | COO | $72.3K | — |
| 4 | Rosenberg Noah L. | CMO | $40.6K | — |
| 5 | Kirby John J. | Interim CFO | $39.6K | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:00 | 2026-08-18 | VRCA | Verrica Pharmaceuticals Inc. | Kirby John J. | Interim CFO | P - Purchase | $4.93 | +5,000 | 24.0K | +26% | +$24.6K | |
| 2025-12-30 | 2025-12-23 | VRCA | Verrica Pharmaceuticals Inc. | Kirby John J. | Interim CFO | A - Grant | $0.00 | +10.0K | 19.0K | +112% | $0 | |
| D | 2025-11-25 | 2025-11-25 | VRCA | Verrica Pharmaceuticals Inc. | Kirby John J. | Interim CFO | P - Purchase | $4.24 | +3,536 | 8,962 | +65% | +$15.0K |
| 2024-11-06 | 2024-11-06 | VRCA | Verrica Pharmaceuticals Inc. | Kirby John J. | Interim CFO | A - Grant | $0.00 | +54.3K | 54.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations